Centre proposes minimum 12-month shelf life rule for imported drugs

The government is considering a rule change to mandate a minimum 12-month shelf life for imported drugs, up from the current 60% residual shelf life. This move aims to enhance drug safety and ensure that medications imported into the country are within a reliable timeframe for efficacy and stability. Such a regulation could potentially reduce the risk of patients receiving ineffective or harmful medications, which is crucial for maintaining public health standards. The proposal highlights a shift towards stricter quality control measures for imported pharmaceuticals.